Indication

Unverricht-Lundborg Disease

1 clinical trial

1 product

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy and Safety of Brivaracetam Used as Adjunctive Treatment for 12 Weeks in Adolescent and Adult Patients (≥ 16 Years) With Genetically Ascertained Unverricht-Lundborg Disease

Status: Completed, Estimated PCD: 2008-01-01

Product